Amarin Corporation Probability Of Bankruptcy

  

Probability Of Bankruptcy Analysis

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis. The score is used to predict probability of a firm or a fund experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin Corporation 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
68 %

Distress Driver Correlations

About Probability Of Bankruptcy

Probability of Bankruptcy SHOULD NOT be confused with actual chance of a company to file for chapter 7, 11, 12 or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty to meet its current financial obligations towards its creditors or to deliver on the expectations of its investors. Macroaxis derives these conditions on a daily bases from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns including short term and long term historical volatility. Other factors taken into account include analysis of liquidity, revenues patterns, RND expenses, as well as public headlines and social sentiment.
Compare Amarin Corporation to competition

Amarin Corporation Probability Of Bankruptcy Assessment

  Of Bankruptcy 
Benchmark  Embed   Amarin Corporation Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 68%. This is 49.65% higher than that of the Healthcare sector, and 9.8% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 57.96% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Probability Of Bankruptcy

Probability Of Bankruptcy Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Showing first 21 of many similar equities found by Probability Of Bankruptcy
NVO NYQNovo Nordisk AS
2 %
TEVA NYQTeva Pharmaceutical Industries Limited
37 %
RDY NYQDr Reddys Laboratories Ltd
6 %
TARO NYQTaro Pharmaceutical Industries Ltd
3 %
UTHR NMSUnited Therapeutics Corporation
3 %
ENDP NMSEndo International plc
41 %
DEPO NMSDepomed Inc
39 %
AMPH NMSAmphastar Pharmaceuticals Inc
3 %
AMRN NGMAmarin Corporation plc
68 %
SCLN NMSSciClone Pharmaceuticals Inc
2 %
IONS NMSIonis Pharmaceuticals Inc
20 %
IPCI NCMIntelliPharmaCeutics International Inc
14 %
IPXL NMSImpax Laboratories Inc
39 %
NK NMSNantKwest Inc
9 %
KG ASEKing Pharmaceuticals Inc
35 %
WX NYQWuXi PharmaTech Inc
1 %
IRWD NMSIronwood Pharmaceuticals Inc
42 %
ISTA ASEISTA Pharmaceuticals Inc
52 %
ISPH ASEInspire Pharmaceuticals Inc
60 %
ITEK NGMInotek Pharmaceuticals Corporation
4 %
ITCI NMSIntraCellular Therapies Inc
62 %
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Amarin Corporation Probability Of Bankruptcy Comparison
  Probability Of Bankruptcy 
Benchmark  Embed   Amarin Corporation Comparables 
Amarin Corporation is number one stock in probability of bankruptcy category among related companies.
Did you try this?
Run Money Flow Index Now
   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
Hide  View All  NextLaunch Money Flow Index
Return On Asset(29.88) %
Profit Margin(89.62) %
Operating Margin(76.74) %
Current Valuation757.3 M
Shares Outstanding184.55 M
Shares Owned by Insiders10.16 %
Shares Owned by Institutions29.30 %
Number of Shares Shorted16.77 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales5.34 times
Revenue106.77 M
Gross Profit53.88 M
EBITDA(81.13 M)
Net Income(97.34 M)
Cash and Equivalents72.49 M
Cash per Share0.39 times
Total Debt246.61 M
Current Ratio1.50 times
Book Value Per Share(1.02) times
Cash Flow from Operations(80.27 M)
Short Ratio11.41 times
One Year High3.46
One Year Low1.24
Earnings Per Share(0.53) times
Price to Earnings To Growth(0.03) times
Number of Employees210
Beta0.76
Market Capitalization583.18 M
Total Asset147.64 M
Retained Earnings(1.16 B)
Working Capital38.66 M
Current Asset116.51 M
Current Liabilities77.85 M
Z Score-8.6